Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-01
2009-12-15
Chu, Yong (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S509000, C514S414000, C514S415000
Reexamination Certificate
active
07632955
ABSTRACT:
Indole compounds of the formula:wherein L1, L2, R1, R2, Ra, Rb, Rc, Rd, and Reare defined herein. Also disclosed are methods of using of the indole compounds in inhibiting tubulin polymerization and treating cancer and other angiogenesis-related disorders.
REFERENCES:
patent: 3316260 (1967-04-01), Shen
patent: 3351630 (1967-11-01), Shen
patent: 3489429 (1970-01-01), Herbst et al.
patent: 3489770 (1970-01-01), Herbst et al.
patent: 3557142 (1971-01-01), Bell
patent: 3594391 (1971-07-01), Wolf et al.
patent: 3781300 (1973-12-01), Wolf et al.
patent: 5013837 (1991-05-01), Ward et al.
patent: 5468898 (1995-11-01), Huang et al.
patent: 5486525 (1996-01-01), Summers et al.
patent: 5753664 (1998-05-01), Aono et al.
patent: 5760040 (1998-06-01), Yoshida et al.
patent: 5952355 (1999-09-01), Ikeda et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6162930 (2000-12-01), Pinney et al.
patent: 6350777 (2002-02-01), Pinney et al.
patent: 6515141 (2003-02-01), Goto et al.
patent: 6787651 (2004-09-01), Stolle et al.
patent: 6933316 (2005-08-01), Hsish et al.
patent: 2004/0167030 (2004-08-01), Bernotas et al.
patent: 2004/0259936 (2004-12-01), Nagarkatti et al.
patent: 2006/0030583 (2006-02-01), Arnold et al.
patent: 2007/0049615 (2007-03-01), Ibrahim et al.
patent: 2257867 (1974-06-01), None
patent: 199 47 863 (2001-04-01), None
patent: 2181559 (1973-12-01), None
patent: WO 92/06088 (1992-04-01), None
patent: WO93/13099 (1993-07-01), None
patent: WO 95/14003 (1995-05-01), None
patent: WO 98/08818 (1998-03-01), None
patent: WO 00/48606 (2000-08-01), None
patent: WO 00/51983 (2000-09-01), None
patent: WO00/53582 (2000-09-01), None
patent: WO 01/09103 (2001-02-01), None
patent: WO 01/19794 (2001-03-01), None
patent: WO 01/19794 (2001-03-01), None
patent: WO 01/28557 (2001-04-01), None
patent: W O0132621 (2001-05-01), None
patent: WO01/68654 (2001-09-01), None
patent: WO 01/68654 (2001-09-01), None
patent: WO02/36561 (2002-05-01), None
patent: WO 02/36561 (2002-05-01), None
patent: WO02/36597 (2002-05-01), None
patent: WO 02/50007 (2002-06-01), None
patent: WO 02/060872 (2002-08-01), None
patent: WO03/101990 (2003-12-01), None
patent: WO2004/009600 (2004-01-01), None
patent: WO2006/015123 (2006-02-01), None
Abstract of Canadian Journal of Chemistry, Disanayaka et al., 1987, 65(2), pp. 245-250.
Santiago et al., Journal of Organic Chemistry, 1995, 60(20), pp. 6318-6326.
Cited—reference—STN—11195524C.
Arya et al., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1977), 15(B), p. 473-7.
Powell et al., “Further Examples of Preferred Transition State Geometries in the Oxidative Cyclisation of Indole and Isoquinoline Derivatives,” Tetrahedron Letters, vol. 22, pp. 4751-4754, 1981.
Goto et al. , 2000, STN International CAPLUS database, Columbus, Ohio, Accession No. 2001:167965.
Angiogenesis [internet May 1, 2007] http://cancer.gov/cancertopics/understandingcancer/angiogenesis/Slide26>.
Angiognesis Inhibitors in the Treatment of Cancer, [internet May 1, 2007] <http://www.cancer.gov/cancertopis/factsheet/Therapy/angiogenesis-inhibitors/print?page=&keyword=)>.
Goloub et al., Oct. 15, 1999, Science, 286: 531-537.
Goto et al. , 2000, STN International CAPLUS database, Columbus, Ohio, Accession No. 2001:167965.
Griffioen et al., Pharmacological Reviews 52(2):237-268 2000.
Homma et al., Journal of National Cancer Institute, 89(11):803-807 Jun. 1997.
Hortobagyi, G., Oct. 1, 1998, N. Eng. J. Med., 339:974-984.
Kimmel et al., J. Neurosurg. 66:161-171 1987.
Kuo et al., “BPR0L075, A Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo,” Cancer Research, 64:4621-4628 (2004).
Liou et al., “Concise Synthesis and Structure- Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents,” J. Med. Chem. 47:4247-4257 (2004).
Minakata et al., “Functionalization of 1H-Pyrrolo[2,3-b]Pyridine,”The Chemical Society of Japan, vol. 65 No. 11, pp. 2992-2997, (1992).
Powell et al., “Further Examples of Preferred Transition State Geometries in the Oxidative Cyclisation of Indole and Isoquinoline Derivatives,” Tetrahedron Letters, vol. 22, pp. 4751-4754, 1981.
Samson et al., Chemotherapy Sensitivity and Resistance Assays; A Systematic Review, Sep. 1, 2004, J. Clinical Oncology 22(11): 3618-3630.
Song et al., “Isomerism of Bis(7-azaindolyl)Methane,”Organic Letters, vol. 4, No. 23, pp. 4049-4052, (2002).
Yakhontov et al., “Derivatives of 7-Azaindole XV Electrophilic Substitution in 4-Methyl-7-Azaindole and Its Derivatives,” (UDC 547.836.3) S. Ordzhonikidze All-Union Scientific Research Institute for Chemical Pharmaceutics, 1(11):2032-2040 (1965) (Original Article Submitted Jul. 20, 1964) (Including its English Publication and the English Abstract of its Russian Publication.
Yeung et al., “Friedel-Crafts Acylation of Indoles in Acidic Imidazolium Chloroaluminate Ionic Liquid at Room Temperature,”Tetrahedron Letters, vol. No. 43, pp. 5793-5795, (2002).
“Synthesis and Psychopharmacoligical Evaluation of Some 4-(3′-Indolylidene)—2 Methyl-2- Oxazolin -5- One Analogues,” Indian Drugs vol. 29 Issue 2 pp. 87-90 (1991).
Boltze et al., “Chemishce Struktur und antiphlogistische Wirkung in der Reihe der substiutierten Indo1-3-essigsauren,” Arzneimittel-Forschung, vol. 30, Issue 8A, pp. 1314-1325, 1980.
Arya et al., “Synthesis & CNS Depressant Activity of Some 2,3-Disubstituted Indoles,” Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, vol. 15B, Issue 5, pp. 473-477, 1977.
Almirante et al., “Sintesi E Attivita' Farmacologica Di N-Acil Derivati Di Indoli E Di Altri Anelli Eterociclici Correlati,” Bollettino Chimico Farmaceutico, vol. 112, Issue 2, pp. 94-103, 1973.
Bikova et al., “Synthesis and pharmacological study of analogs of the antirheumatic preparation indomethacin,” Trudove na Nauchnoizsledovatelskiya Khimikofarmatsevtichen Institut, vol. 8, pp. 101-112 (English Abstract Only), 1972.
Chang Chun-Wei
Chang Jang-Yang
Hsieh Hsing-Pang
Liou Jing-Ping
Chu Yong
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Indole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108470